Beijing has joined several other Chinese cities in introducing online drug purchase services via individual medical insurance accounts. This initiative aims to enhance convenience for residents by allowing them to purchase over-the-counter drugs through platforms like Meituan and JD.
The Beijing Municipal Medical Insurance Bureau announced that insured individuals can now use their personal medical insurance accounts to buy medications from 300 designated pharmacies across the city. Delivery and packaging costs will be covered by the purchaser, with the online platforms ensuring prompt delivery post-order placement.
Local resident Li Yubo shared his positive experience with the new service, highlighting its simplicity and convenience. “It’s so handy that I don’t need to rush out on foot to buy medicine for a fever when I feel terrible. It’s a lovely policy for single people like me,” he remarked.
The initiative covers all districts in Beijing through 300 designated retail pharmacies. Looking ahead, the Medical Insurance Bureau plans to explore the feasibility of online purchases for prescription drugs to further streamline services for insured individuals. It also aims to expand the network of designated pharmacies and ensure strict supervision to maintain the efficiency and safety of medical insurance funds.
Some pharmacies have already noted an impact on offline drug purchases due to the new policy. While acknowledging the convenience for younger demographics, a staff member from Jinxiang pharmacy highlighted potential challenges for elderly users who may prefer in-person consultations.
Beijing resident Li Xiaoli, who encountered initial payment issues, suggested improvements in the payment platform to enhance user experience. “It’s new. It takes time to be better,” she commented.
The introduction of online pharmaceutical retail channels aligns with China’s broader initiative to integrate “Internet + medical services,” facilitating seamless prescription circulation, online payment settlement, and home delivery of medicines. Similar programs have been piloted in other cities like Shanghai and several cities in Guangdong province since July 2021, signaling a growing trend in digital healthcare accessibility.
This move reflects China’s commitment to leveraging technology to improve healthcare access and efficiency, particularly in urban centers grappling with healthcare service demands.
